Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rescigno

Showing results (601-610 of 1,117) with videos related to

Pageof 112
Sort By:
Frontiers in Molecular Biosciences|September 20, 2021
Resveratrol-Based Nanoformulations as an Emerging Therapeutic Strategy for CancerJavad Sharifi-Rad, Cristina Quispe, Zhazira Mukazhanova, et al.
Breast Cancer Research : BCR|May 1, 2019
Germline loss-of-function variants in the BARD1 gene are associated with early-onset familial breast cancer but not ovarian cancerNana Weber-Lassalle, Julika Borde, Konstantin Weber-Lassalle, et al.
European Urology|June 9, 2021
Elucidating Prostate Cancer Behaviour During Treatment via Low-pass Whole-genome Sequencing of Circulating Tumour DNASemini Sumanasuriya, George Seed, Harry Parr, et al.
Immunotherapy|January 20, 2025
Role of Hb to RDW ratio in metastatic renal cell carcinoma patients treated with first-line immunotherapy combinationsMatilde Corianò, Alessandro Lazzarin, Michele Maffezzoli, et al.
Current Oncology (Toronto, Ont.)|June 25, 2026
Real-World Analysis of Metastatic Renal Cell Carcinoma Patients Treated with Pembrolizumab Plus Axitinib: Evidence from the Campania Oncology NetworkMarilena Di Napoli, Elisabetta Coppola, Carmine D'Aniello, et al.
Cancer Cell|April 2, 2021
Gut vascular barrier impairment leads to intestinal bacteria dissemination and colorectal cancer metastasis to liverAlice Bertocchi, Sara Carloni, Paola Simona Ravenda, et al.
Plos One|September 14, 2021
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA studyPia Clara Pafundi, Raffaele Galiero, Vittorio Simeon, et al.
Oncotarget|November 28, 2018
EpCAM<sup>high</sup> and EpCAM<sup>low</sup> circulating tumor cells in metastatic prostate and breast cancer patientsSanne de Wit, Mariangela Manicone, Elisabetta Rossi, et al.
Cancer Immunology, Immunotherapy : CII|May 9, 2025
Pembrolizumab plus Lenvatinib in patients with metastatic Renal Cell Carcinoma: real-world evidences from the international ARON- 1 studyCamillo Porta, Francesco Massari, Tarek Taha, et al.
Plos One|December 10, 2020
Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA studyRaffaele Galiero, Pia Clara Pafundi, Vittorio Simeon, et al.
Pageof 112

Showing results (601-610 of 1,117) with videos related to

Sort By:
Pageof 112
Frontiers in Molecular Biosciences|September 20, 2021
Resveratrol-Based Nanoformulations as an Emerging Therapeutic Strategy for CancerJavad Sharifi-Rad, Cristina Quispe, Zhazira Mukazhanova, et al.
Breast Cancer Research : BCR|May 1, 2019
Germline loss-of-function variants in the BARD1 gene are associated with early-onset familial breast cancer but not ovarian cancerNana Weber-Lassalle, Julika Borde, Konstantin Weber-Lassalle, et al.
European Urology|June 9, 2021
Elucidating Prostate Cancer Behaviour During Treatment via Low-pass Whole-genome Sequencing of Circulating Tumour DNASemini Sumanasuriya, George Seed, Harry Parr, et al.
Immunotherapy|January 20, 2025
Role of Hb to RDW ratio in metastatic renal cell carcinoma patients treated with first-line immunotherapy combinationsMatilde Corianò, Alessandro Lazzarin, Michele Maffezzoli, et al.
Current Oncology (Toronto, Ont.)|June 25, 2026
Real-World Analysis of Metastatic Renal Cell Carcinoma Patients Treated with Pembrolizumab Plus Axitinib: Evidence from the Campania Oncology NetworkMarilena Di Napoli, Elisabetta Coppola, Carmine D'Aniello, et al.
Cancer Cell|April 2, 2021
Gut vascular barrier impairment leads to intestinal bacteria dissemination and colorectal cancer metastasis to liverAlice Bertocchi, Sara Carloni, Paola Simona Ravenda, et al.
Plos One|September 14, 2021
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA studyPia Clara Pafundi, Raffaele Galiero, Vittorio Simeon, et al.
Oncotarget|November 28, 2018
EpCAM<sup>high</sup> and EpCAM<sup>low</sup> circulating tumor cells in metastatic prostate and breast cancer patientsSanne de Wit, Mariangela Manicone, Elisabetta Rossi, et al.
Cancer Immunology, Immunotherapy : CII|May 9, 2025
Pembrolizumab plus Lenvatinib in patients with metastatic Renal Cell Carcinoma: real-world evidences from the international ARON- 1 studyCamillo Porta, Francesco Massari, Tarek Taha, et al.
Plos One|December 10, 2020
Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA studyRaffaele Galiero, Pia Clara Pafundi, Vittorio Simeon, et al.
Pageof 112